The cortisol testing kits market size is projected to be worth USD 184.6 million in 2023. The market is likely to surpass USD 340.7 million by 2033 at a CAGR of 6.3% during the forecast period. The market growth is being propelled by several factors, including the increasing prevalence of hormonal disorders & growing awareness and focus on stress-related health issues. Additionally, the COVID-19 pandemic has further accelerated the demand for at-home health monitoring options.
Technological advancements have significantly improved cortisol testing kits. The integration of advanced biosensor technologies, wearable devices, and smartphone applications has enhanced the accuracy, ease of use, and accessibility of cortisol testing. These advancements have expanded the market by making cortisol testing more convenient and efficient.
Other Drivers Propelling the Demand for Cortisol Testing Kits include:
Challenges for Companies /Manufacturers in the Cortisol Testing Kits Market:
Opportunities in the Cortisol Testing Kits Industry:
Latest Trends in the Cortisol Testing Kits Market:
| Attributes | Details |
|---|---|
| Cortisol Testing Kits Market Size (2023) | USD 184.6 million |
| Cortisol Testing Kits Market Projected Size (2033) | USD 340.7 million |
| Value CAGR (2023 to 2033) | 6.3% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
From 2017 to 2022, the global cortisol testing kits market experienced a CAGR of 5.1%, reaching a market size of USD 184.6 million in 2023.
From 2017 to 2022, Over the past two decades, there has been a growing recognition of the importance of cortisol testing in diagnosing hormonal disorders such as adrenal insufficiency and Cushing's syndrome. As awareness about these conditions has increased, there has been a corresponding rise in the demand for cortisol testing kits, leading to market growth.
Future Forecast for Cortisol Testing Kits Industry:
Looking ahead, the global cortisol testing kits industry is expected to rise at a CAGR of 6.3% from 2023 to 2033. During the forecast period, the market size is expected to reach USD 340.7 million by 2033.
The cortisol testing kits industry is expected to continue its growth trajectory from 2023 to 2033, driven by the adoption of remote patient monitoring and telehealth solutions. The integration of cortisol testing kits with digital health solutions, such as smartphone apps and wearable devices, is expected to continue.
These digital tools can facilitate convenient testing, real-time data tracking, and remote monitoring of cortisol levels. The ability to collect and analyze data seamlessly can lead to improved patient management and better healthcare outcomes, driving the growth of cortisol testing kits.
| Country | The United States |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 111.4 million |
| CAGR % 2023 to End of Forecast (2033) | 6.1% |
The cortisol testing kits industry in the United States is expected to reach a market size of USD 111.4 million by 2033, expanding at a CAGR of 6.1%. Chronic diseases and conditions, such as diabetes, obesity, and cardiovascular diseases, are prevalent in the United States. There is a well-established link between stress and the development or exacerbation of these conditions. Cortisol testing kits play a crucial role in assessing stress levels and monitoring the impact of stress on disease management.
| Country | The United Kingdom |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 15.4 million |
| CAGR % 2023 to End of Forecast (2033) | 6.0% |
The cortisol testing kits industry in the United Kingdom is expected to reach a market share of USD 15.4 million, expanding at a CAGR of 6.0% during the forecast period. The United Kingdom has witnessed a shift towards self-care and wellness, with individuals taking a proactive approach to managing their health. Cortisol testing kits offer a convenient and accessible way for individuals to monitor their stress levels at home. The ability to track cortisol levels empowers individuals to make informed lifestyle choices, seek appropriate interventions, and take control of their well-being.
| Country | China |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 24.4 million |
| CAGR % 2023 to End of Forecast (2033) | 7.3% |
The cortisol testing kits industry in China is anticipated to reach a market size of USD 24.4 million, moving at a CAGR of 7.3% during the forecast period. Technological advancements in cortisol testing have made the process more accurate, efficient, and user-friendly. Portable and rapid cortisol testing kits enable healthcare providers to obtain immediate results, facilitating timely diagnosis and treatment decisions.
| Country | Japan |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 17.8 million |
| CAGR % 2023 to End of Forecast (2033) | 7.2% |
The cortisol testing kits industry in Japan is estimated to reach a market size of USD 17.8 million by 2033, thriving at a CAGR of 7.2%. Collaboration between the medical device industry and healthcare providers is driving the adoption of cortisol testing kits in Japan. Manufacturers and suppliers of cortisol testing kits are working closely with healthcare professionals to develop and promote the use of these kits for stress assessment and management.
| Country | South Korea |
|---|---|
| Market Size (USD million) by End of Forecast Period (2033) | USD 20.2 million |
| CAGR % 2023 to End of Forecast (2033) | 7.0% |
The cortisol testing kits industry in South Korea is expected to reach a market size of USD 20.2 million, expanding at a CAGR of 7.0% during the forecast period. South Korea has been increasing its healthcare spending, leading to improved access to healthcare services and medical devices. With greater access to healthcare facilities, there is a higher demand for medical devices, including cortisol testing kits, to support diagnosis, monitoring, and treatment. The increased healthcare spending provides opportunities for manufacturers and suppliers of cortisol testing kits to cater to the growing demand.
Principal Consultant
ELISA is expected to dominate the cortisol testing kits industry with a CAGR of 6.5% from 2023 to 2033. ELISA-based cortisol testing kits offer high sensitivity and specificity, allowing for accurate measurement of cortisol levels in biological samples. These kits have a lower limit of detection that enables the quantification of cortisol even at low concentrations, making them suitable for a wide range of applications.
Hyperthyroidism is expected to dominate the cortisol testing kits industry with a CAGR of 6.4% from 2023 to 2033. Cortisol testing may still have some relevance in cases where hyperthyroidism is suspected to be caused by another condition or is associated with stress-related disorders. In such cases, cortisol testing can help evaluate the impact of stress on the body or assess the function of the adrenal glands, which are involved in cortisol production. This information may complement the overall assessment of a patient with suspected or diagnosed hyperthyroidism.
Whole blood is expected to dominate the cortisol testing kits industry with a CAGR of 6.1% from 2023 to 2033. Cortisol testing kits that utilize whole blood as the sample type are available for measuring cortisol levels. These kits are designed to provide a convenient and rapid method for cortisol analysis in whole blood samples. Whole blood cortisol testing kits are designed to provide rapid results, often within minutes. This quick turnaround time allows for immediate assessment of cortisol levels, enabling timely decision-making and intervention if necessary.
Diagnostics centers is expected to dominate the cortisol testing kits industry with a CAGR of 6.5% from 2023 to 2033. Diagnostics centers can play a significant role in offering cortisol testing services using cortisol testing kits. These centers, equipped with appropriate laboratory facilities and trained personnel, can perform cortisol testing to assess stress levels and aid in the diagnosis and management of certain conditions.
Cortisol testing kits industry is fiercely competitive, with many companies fighting for market dominance. To stay ahead of the competition in such a circumstance, essential players must employ smart techniques.
Key Strategies Used by the Participants
Companies invest heavily in R&D to develop testing kits that improve efficiency, accuracy, and cost-effectiveness. Technology innovation allows businesses to differentiate themselves from their competition while also catering to the changing demands of their consumers.
Key industry leaders frequently develop strategic partnerships and collaborations with other companies in order to harness their strengths and increase their market reach. Companies might also gain access to new technology and markets through such agreements.
Cortisol testing kits industry is expanding rapidly in emerging regions such as China and India. Key firms are enhancing their distribution networks and developing local manufacturing facilities to increase their presence in these areas.
Mergers and acquisitions are frequently used by key players in the cortisol testing kits business to consolidate their market position, extend their product range, and gain access to new markets.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Key Developments in the Cortisol testing kits Market:
The sales of cortisol testing kits are anticipated to be USD 340.7 million by 2033.
The growth potential of the market is 6.3% through 2033.
Growing hormonal disorders and surging awareness about the adverse impact of stress.
Dearth of standardized protocols and increasing costs of cortisol testing kits.
Point-of-care testing and self-monitoring are the emerging trends in the market.
1. Executive Summary 2. Market Overview 3. Key Market Trends 4. Value Added Insights 5. Market Background 6. Global Market Volume (in Units) Analysis 2017 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Technique 9.1. RIA: Radioimmunoassay 9.2. CMIA: Chemiluminescent Microparticle Immunoassay 9.3. CLIA: Chemiluminescence Immunoassay 9.4. ECLIA: Electrochemiluminescence Immunoassay 9.5. FPIA: Fluorescence Polarization Immunoassay 9.6. ELISA: Enzyme-linked Immunosorbent Assay 9.7. Mass Spectrometry 10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication 10.1. Cushing’s Syndrome 10.2. Adrenal Cortical Dysfunction 10.3. Addison Disease 10.4. Hyperthyroidism 10.5. Chronic Stress 11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Sample 11.1. Whole Blood 11.2. Serum 11.3. Plasma 11.4. Urine 11.5. Dry Faecal 11.6. Others 12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 12.1. Hospital Settings 12.2. Specialty Clinics 12.3. Diagnostics Centers 12.4. Nephropathy Clinics 12.5. Others 13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region 13.1. North America 13.2. Latin America 13.3. Europe 13.4. South Asia 13.5. East Asia 13.6. Oceania 13.7. Middle East and Africa 14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 15. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033 16. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033 17. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033 19. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033 20. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033 21. Market Structure Analysis 22. Competition Analysis 22.1. Abbott 22.2. Beckman 22.3. Roche 22.4. Siemens 22.5. arigo Biolaboratories Corp 22.6. Eagle Biosciences, Inc. 22.7. Monobind Inc. 22.8. Snibe 22.9. Elabscience Biotechnology Inc 22.10. Thermo Fisher Scientific Inc 22.11. bioMérieux SA 22.12. Salimetrics 22.13. Caymanchem 23. Assumptions and Acronyms Used 24. Research Methodology
Explore Healthcare Insights
View Reports
Cortisol Testing Kits Market
